Recombinant Vaccinia/Venezuelan Equine Encephalitis (VEE) Virus Expresses VEE Structural Proteins

References

1. ALEVIZATOS A. C, MCKLNNEY R. W., FERGIN R. D. 1967; Live attenuated Venezuelan equine encephalomyelitis virus vaccine. I. Clinical effects in man. American Journal of Tropical Medicine and Hygiene 16:762–768
   [Google Scholar]
2. BAKER E. F. JR, SASSO D. R., MANESS K., PRICHARD W. D., PARKER R. L. 1978; Venezuelan equine encephalomyelitis vaccine (strain TC-83): a field study. American Journal of Veterinary Research 39:1627–1631
   [Google Scholar]
3. BERGE T. O., BANKS I. S., TIGERTT W. D. 1961; Attenuation of Venezuelan equine encephalomyelitis virus by in vitro cultivation in guinea-pig heart cells. American Journal of Hygiene 73:209–218
   [Google Scholar]
4. CALISHER C. H., MANESS K. S. C. 1975; Laboratory studies of Venezuelan equine encephalitis virus in equines, Texas, 1971. Journal of Clinical Microbiology 2:198–205
   [Google Scholar]
5. EDDY G. A., MARTIN D. H., REEVES W. C., JOHNSON K. M. 1972; Field studies of an attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83). Infection and Immunity 5:160–163
   [Google Scholar]
6. ESPOSITO J., CONDIT R., OBIJESKI J. 1981; The preparation of orthopoxvirus DNA. Journal of Virological Methods 2:175–179
   [Google Scholar]
7. ESPOSITO J., BRECHLING K., BAER G., MOSS B. 1987; Vaccinia virus recombinants expressing rabiesvirus glycoprotein protect against rabies. Virus Genes 1:7–21
   [Google Scholar]
8. FRANCE J. K., WYRICK B. C., TRENT D. W. 1979; Biochemical and antigenic comparisons of the envelope glycoproteins of Venezuelan equine encephalomyelitis virus strains. Journal of General Virology 44:725–740
   [Google Scholar]
9. FRANKE C. A., BERRY E. S., SMITH A. W., HRUBY D. E. 1985; Immunization of cattle with a recombinant togavirus-vaccinia virus strain. Research in Veterinary Science 39:113–115
   [Google Scholar]
10. GROOT H. 1972 The health and economic impact of Venezuelan equine encephalitis (VEE). Venezuelan Encephalitis7–16 Scientific Publication no. 243 Washington, D.C.: Pan American Health Organization;
    [Google Scholar]
11. HAMMON W. McD., SATHER G. E. 1969 Arboviruses. Diagnostic Procedures for Viral and Rickettsial Infections, 4th edn.227–280 Edited by Lennette E. H., Schmidt N. J. New York: American Public Health Association;
    [Google Scholar]
12. HUNT A. R., ROEHRIG J. T. 1985; Biochemical and biological characteristics of epitopes on the E1 glycoprotein of western equine encephalitis virus. Virology 142:334–346
    [Google Scholar]
13. JÄHRLING P. B., STEPHENSON E. H. 1984; Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters. Journal of Clinical Microbiology 19:429–431
    [Google Scholar]
14. JOHNSON B. J. B., KINNEY R. M., KOST C. L., TRENT D. W. 1986; Molecular determinants of alphavirus neurovirulence: nucleotide and deduced protein sequence changes during attentuation of Venezuelan equine encephalitis virus. Journal of General Virology 67:1951–1960
    [Google Scholar]
15. KINNEY R. M., JOHNSON B. J. B., BROWN V. L., TRENT D. W. 1986; Nucleotide sequence of the 26S mRNA of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and deduced sequence of the encoded structural proteins. Virology 152:400–413
    [Google Scholar]
16. LONDON W. T., LEVITT N. H., KENT S. G., WONG V. G., SEVER J. L. 1977; Congenital cerebral and ocular malformations induced in rhesus monkeys by Venezuelan equine encephalitis virus. Teratology 16:285–296
    [Google Scholar]
17. LORD R. 1974; History and geographic distribution of Venezuelan equine encephalitis. Bulletin of the Pan American Health Organization 8:100–110
    [Google Scholar]
18. MACKETT M., SMITH G. L. 1986; Vaccinia virus expression vectors. Journal of General Virology 67:2067–2082
    [Google Scholar]
19. MACKETT M., SMITH G. L., MOSS B. 1982; Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proceedings of the National Academy of Sciences, U.S.A 79:7415–7419
    [Google Scholar]
20. MACKETT M., SMITH G. L., MOSS B. 1984; General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. Journal of Virology 49:857–864
    [Google Scholar]
21. MCKLNNEY R. W. 1972 Inactivated and live VEE vaccines—a review. Venezuelan encephalitis369–384 Scientific Publication no. 243 Washington, D.C.: Pan American Health Organization;
    [Google Scholar]
22. MCKINNEY R. W., BERGE T. O., SAWYER W. D., TIGERTT W. D., CROZIER D. 1963; Use of an attenuated strain of Venezuelan equine encephalomyelitis virus for immunization in man. American Journal of Tropical Medicine and Hygiene 12:597–603
    [Google Scholar]
23. MANIATIS T., FRITSCH E. F., SAMBROOK J. 1982 Molecular Cloning: A Laboratory Manual New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
24. MATHEWS I. H., ROEHRIG J. T. 1982; Determination of the protective epitopes on the glycoproteins of Venezuelan equine encephalomyelitis virus by passive transfer of monoclonal antibodies. Journal of Immunology 129:2763–2767
    [Google Scholar]
25. RICE C. M., FRANKE C. A., STRAUSS J. H., HRUBY D. E. 1985; Expression of Sindbis virus structural proteins via recombinant vaccinia virus: synthesis, processing, and incorporation into mature Sindbis virions. Journal of Virology 56:227–239
    [Google Scholar]
26. ROEHRIG J. T., MATHEWS J. H. 1985; The neutralization site on the E2 glycoprotein of Venezuelan equine encephalomyelitis (TC-83) virus is composed of multiple conformationally stable epitopes. Virology 142:347–356
    [Google Scholar]
27. ROEHRIG J. T., DAY I. W., KINNEY R. M. 1982; Antigenic analysis of the surface glycoproteins of a Venezuelan equine encephalomyelitis virus (TC-83) using monoclonal antibodies. Virology 118:269–278
    [Google Scholar]
28. ROEHRIG J. T., HUNT A. R., KINNEY R. M., MATHEWS J. H. 1988; In vitro mechanisms of monoclonal antibody neutralization of alphaviruses. Virology 165:66–73
    [Google Scholar]
29. SCHLESINGER M. J., KAÄKIÄINEN L. 1980 Translation and processing of alphavirus proteins. The Togaviruses: Biology, Structure, Replication371–392 Edited by Schlesinger R. W. New York & London: Academic Press;
    [Google Scholar]
30. SCHMALJOHN A. L., JOHNSON E. D., DALRYMPLE J. M., COLE G. A. 1982; Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis. Nature, London 297:70–72
    [Google Scholar]
31. TOWBIN H., STAEHLIN T., GORDON J. 1979; Electrophoretic transfer of proteins from Polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences, U.S.A 76:4350–4354
    [Google Scholar]
32. TRENT D. W., CLEWLEY J. P., FRANCE J. K., BISHOP D. H. L. 1979; Immunochemical and oligonucleotide fingerprint analyses of Venezuelan equine encephalomyelitis complex viruses. Journal of General Virology 43:365–381
    [Google Scholar]
33. WALTON T. E., BRANTIGAM F. E., FERRER J. A., JOHNSON K. M. 1972; Epizootic Venezuelan equine encephalomyelitis in Central America. Disease pattern and vaccine evaluation in Nicaragua, 1969-1970. American Journal of Epidemiology 95:247–254
    [Google Scholar]